A fungus that can live unnoticed on human skin has become a serious threat in hospitals around the world. First identified in Japan in 2009, Candida auris can become deadly if it enters the ...
Astronomers studying one of the most magnetic objects in the universe have found some of the strongest evidence yet for a bizarre effect predicted by quantum physics nearly 90 years ago. The finding ...
A tiny fossil overlooked for decades at La Brea Tar Pits has turned out to belong to a species previously unknown to science.
Researchers from the University of Technology Sydney (UTS), Harvard, and Henan universities have developed a ‘double punch’ nanozyme platform intended to tackle both problems using the same smart ...
A Neanderthal-derived growth hormone receptor still carried by some people today appears to amplify growth-related signals in cells.
The researchers made the measurement at the Chooz nuclear power plant in northern France. About 400 meters from its two reactor cores, the Double Chooz detector sits underground and contains more than ...
The pain and urgent need to urinate during a urinary tract infection (UTI) may be more than unpleasant symptoms. Australian researchers have identified a little-understood group of nerves near the ...
Spacecraft measurements may make highly organized particle motion in Earth’s radiation belts look random, potentially obscuring the physics driving these hazardous environments. Credit: Shutterstock ...
An illustration of the experimental concept shows how researchers study phases in quantum material. In the background, the uniform blue stripes are the dominant order, and the subtle red stripe ...
The nucleus of the cells of interest has been labeled scarlet. Credit: University of Manchester Researchers found that a little-known group of immune cells is crucial for keeping cancer-fighting T ...
Europe is about to experience a total solar eclipse, and people around the world will be able to watch it live. The European ...
A prescription THC drug made PTSD nightmares disappear for more than one-third of patients in a promising clinical trial.